Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Alleviating obesity-induced chronic low-grade inflammation in the hypothalamus via anti-inflammatory compounds sodium salicylate, and docasahexaenoic acid (DHA)
FY 2014-15
Summary
Obesity is characterized by a state of chronic, low-grade inflammation caused by increase in circulating fatty acid levels, and production of pro-inflammatory cytokines. The hypothalamus is the central regulator of feeding and energy homeostasis. Neuropeptide Y (NPY)/Agouti-related peptide (AgRP) neurons in the arcuate nucleus secrete NPY/AgRP to upstream neurons to stimulate appetite, increase feeding, and decrease energy expenditure. Alternatively, pro-opiomelanocortin (POMC) neurons secrete alpha-melanocyte stimulating hormone to decrease feeding, appetite, and increase energy expenditure.
Neuron inflammation is one factor that can disrupt the NPY/AgRP and POMC regulatory system. Activation of the canonical inhibitor of IkappaB kinase beta/nuclear factor kappa B (IKKb/NFkB) pathway can impair insulin sensitivity, secretion of neuropeptides, and disrupt cellular glucose sensing mechanisms. It has been shown in literature that genetic inhibition of the canonical inflammatory pathway can lead to improvements in metabolic illnesses such as a decrease in food intake, and weight loss. However, the methods of inhibition used in these studies are not optimal for usage in a clinical setting. I wish to study the effects of well-known anti-inflammatory reagents such as sodium salicylate on the IKKb/NFkB pathway in hypothalamic NPY/AgRP and POMC neurons. I hypothesize that treatment with sodium salicylate will alleviate neuronal inflammation via the activation of the deacetylase sirtuin1 to decrease NFkB binding to its promoter region.I will utilize an in vivo mouse model of high-fat diet induced obesity and in vitro immortalized hypothalamic cell models for my studies.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
331477
Name
Ye Wenqing
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Alleviating obesity-induced chronic low-grade inflammation in the hypothalamus via anti-inflammatory compounds sodium salicylate, and docasahexaenoic acid (DHA)
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Alpha-Melanocyte Stimulating Hormone; Energy Homeostasis; Insulin Resistance; Insulin Sensitivity; Metabolism; Neuroendocrinology; Neuroinflammation; Neuropeptide Y; Obesity; Type 2 Diabetes Mellitus
Abstract
Obesity is characterized by a state of chronic, low-grade inflammation caused by increase in circulating fatty acid levels, and production of pro-inflammatory cytokines. The hypothalamus is the central regulator of feeding and energy homeostasis. Neuropeptide Y (NPY)/Agouti-related peptide (AgRP) neurons in the arcuate nucleus secrete NPY/AgRP to upstream neurons to stimulate appetite, increase feeding, and decrease energy expenditure. Alternatively, pro-opiomelanocortin (POMC) neurons secrete alpha-melanocyte stimulating hormone to decrease feeding, appetite, and increase energy expenditure.
Neuron inflammation is one factor that can disrupt the NPY/AgRP and POMC regulatory system. Activation of the canonical inhibitor of IkappaB kinase beta/nuclear factor kappa B (IKKb/NFkB) pathway can impair insulin sensitivity, secretion of neuropeptides, and disrupt cellular glucose sensing mechanisms. It has been shown in literature that genetic inhibition of the canonical inflammatory pathway can lead to improvements in metabolic illnesses such as a decrease in food intake, and weight loss. However, the methods of inhibition used in these studies are not optimal for usage in a clinical setting. I wish to study the effects of well-known anti-inflammatory reagents such as sodium salicylate on the IKKb/NFkB pathway in hypothalamic NPY/AgRP and POMC neurons. I hypothesize that treatment with sodium salicylate will alleviate neuronal inflammation via the activation of the deacetylase sirtuin1 to decrease NFkB binding to its promoter region.I will utilize an in vivo mouse model of high-fat diet induced obesity and in vitro immortalized hypothalamic cell models for my studies.
Competitiondate
201412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ye, Wenqing
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~